Literature DB >> 16162740

Childhood parapneumonic effusions: biochemical and inflammatory markers.

G Eda Utine1, Ugur Ozcelik, Ebru Yalcin, Deniz Dogru, Nural Kiper, Ayse Aslan, Guler Kanra.   

Abstract

STUDY
OBJECTIVES: Biochemical and inflammatory markers in pleural inflammation were evaluated in pediatric cases of parapneumonic effusions, and interleukin (IL)-8 and tumor necrosis factor (TNF)-alpha concentrations were tested for possible differentiation of the complicated nature of effusions. PATIENTS: Twenty-eight patients (12 female) who were admitted to Hacettepe University Childrens' Hospital over a 2-year period were included in the study. MEASUREMENTS: Patients were grouped according to the stage of effusion. Pleural fluid leukocyte count, neutrophil ratio, pH, protein, glucose levels, lactate dehydrogenase (LDH) levels, TNF-alpha levels, IL-8 levels, and nitrite levels were obtained.
RESULTS: Of these patients, 13 had empyema, 10 had complicated parapneumonic effusions (CPEs), and 5 had uncomplicated parapneumonic effusions (UPEs). Protein and glucose levels decreased, leukocyte count, neutrophil ratio, TNF-alpha levels, nitrite levels, and IL-8 levels increased progressively as the stage of the disease progressed. IL-8 levels, but not TNF-alpha and nitrite levels, were statistically different among the groups. IL-8, TNF-alpha, and nitrite levels all correlated positively with each other (all p < or = 0.001), and pH correlated negatively with these markers (all p < or = 0.001). At a cutoff value of 76.6 pg/mL, TNF-alpha discriminated between CPEs and UPEs with a sensitivity of 50%, a specificity of 100%, and an accuracy of 78%. At a cutoff value of 701.6 pg/mL, IL-8 differentiated CPE and UPE with a sensitivity of 80%, a specificity of 80%, and an accuracy of 86%.
CONCLUSIONS: Progressive changes in common biochemical markers (ie, pH, and protein, glucose, and LDH levels) are interrelated during stages of pleural inflammation. IL-8 may be used as an alternative marker for discriminating between CPEs and UPEs in pediatric parapneumonic effusions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162740     DOI: 10.1378/chest.128.3.1436

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  Clinical practice: treatment of childhood empyema.

Authors:  Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

2.  Serum amyloid alpha in parapneumonic effusions.

Authors:  Vagelis Boultadakis; Vasilis Skouras; Demosthenes Makris; Aggeliki Damianaki; Dimitrios J Nikoulis; Theodoros Kiropoulos; Smaragda Oikonomidi; Irene Tsilioni; Konstantinos Gourgoulianis
Journal:  Mediators Inflamm       Date:  2011-08-25       Impact factor: 4.711

3.  Metabolomic Profiling of Infectious Parapneumonic Effusions Reveals Biomarkers for Guiding Management of Children with Streptococcus pneumoniae Pneumonia.

Authors:  Chih-Yung Chiu; Gigin Lin; Mei-Ling Cheng; Meng-Han Chiang; Ming-Han Tsai; Shen-Hao Lai; Kin-Sun Wong; Sen-Yung Hsieh
Journal:  Sci Rep       Date:  2016-04-22       Impact factor: 4.379

4.  Elevated Nitrite/Nitrate Ratio as a Potential Biomarker for the Differential Diagnosis of Pleural Effusions.

Authors:  Mu-Rong Chao; Yuan-Jhe Chang; Ying-Ming Shih; Jian-Lian Chen; Cheng-Chieh Yen; Chiung-Wen Hu
Journal:  Antioxidants (Basel)       Date:  2022-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.